Europe Point-of-Care Molecular Diagnostics Market- Global Drivers, Opportunities, Trends, and Forecasts to 2028

Market Introduction

Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing. Due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes, POCT is rapidly gaining traction.

Moreover, the growing demand for specific viral detection methods that consume less time for timely infection control is expected to bolster the market growth during the forecast period.

๐Ÿ“š ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/TIPRE00026190

In Europe, currently, the UK and Russia are the hardest-hit countries by the COVID-19 pandemic, followed by France, Spain, Italy, and Germany. The implementation of drastic measures and travel restrictions, including closing the borders, impacted the import and export of products, especially in the first half of 2020. The continuous spread of the disease has led to an elevated demand for advanced diagnostic solutions in Europe, thus boosting the adoption of point-of-care molecular diagnostic kits. Moreover, uninterrupted investments and business activities by industry players are also boosting the point-of-care molecular diagnostic market growth. In 2020, European Medicines Agency (EMA) approved ~97 medicines for the marketing authorization, of which 39 were novel drugs. In October 2020, Eurofins introduced PCR-based COVID-19 diagnostic tests with at-home, self-sampling options, in the for European market. In January 2020, European Union (EU) commission announced an emergency call, through which it awarded US$ 55.64 million to 18 research projects. Among these, 3 of the projects are receiving a total of US$ 7.39 million to develop effective, rapid point-of-care diagnostics.

๐Ÿ“š๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‹๐ข๐ง๐ค @ https://www.businessmarketinsights.com/reports/europe-point-of-care-molecular-diagnostics-market

๐“๐ก๐ž ๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ

bioMรฉrieux SA

F. Hoffmann-La Roche Ltd.

Danaher Corporation

Enzo Biochem, Inc.

Abbott

binx health, Inc.

Meridian BioScience, Inc.

Biocartis

Quidel Corporation

Bio-Rad Laboratories, Inc

 

·         Segments Covered

By Product & Services

  • Assays and Kits
  • Instruments
  • Services and Software

By Technology

  • PCR
  • Isothermal Nucleic Acid Amplification Technology
  • Other Technologies

By Application

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Other Applications

By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research and Academic Institutes

 ๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications


 

Comments

Post a Comment

Popular posts from this blog

3D and 4D Technology Market Trends, Size, Share, Growth, Analysis, Forecast to 2031

  The 3D and 4D Technology Market size is expected to reach US$ 1100.92 billion by 2031 from US$ 341.84 billion in 2024. The market is estimated to record a CAGR of 18.2% from 2024 to 2031.   Executive Summary and Global Market Analysis: The Ascendance of 3D and 4D Technologies Introduction: The realm of visual and interactive experiences is undergoing a profound transformation, driven by the rapid evolution of 3D and 4D technologies. These advancements are not merely incremental; they represent a fundamental shift in how we perceive and interact with digital content, bridging the gap between the virtual and the real. 3D technology, by its very nature, introduces depth and volume, moving beyond the flatness of traditional 2D displays. 4D technology, building upon this foundation, adds the critical dimension of time and sensory interaction, creating truly immersive and dynamic experiences. ๐Ÿ“š ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‹๐ข๐ง๐ค @ https://www.businessmarketinsights.com/...
Read more

North America Medical Tubing Market Analytical Overview, Comprehensive Analysis, Segmentation, Poised for Rapid Growth 2028

The North America medical tubing market is expected to grow from US$ 4,753.37 million in 2022 to US$ 6,936.79 million by 2028. It is estimated to record a CAGR of 6.5% from 2022 to 2028.   Increase in Number of Patients Requiring Tube Feeding Drives North America Medical Tubing Market A feeding tube is used to provide nutrients to patients who don’t get enough nutrition from ingested food. A medical tube is inserted in the stomach or small intestine to deliver liquid nutrition directly. ๐Ÿ“š ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/BMIRE00028042 Tube feeding procedure is prescribed to patients suffering from gastrointestinal dysfunction, head and neck cancer (which make swallowing difficult), neurological disorders such as stroke and paralysis, and other medical conditions. Crohn’s disease, a gastrointestinal disease associated with trauma; bowel obstruction (BO); microscopic colitis; short bowel syndrome; and ulcerati...
Read more

North America Ventilators Market Regional Share, Global Size, Trends, Segmentation and Forecast to 2028

The North America ventilators market is expected to grow from US$ 2,053.28 million in 2022 to US$ 3,525.60 million by 2028; it is estimated to register a CAGR of 9.4% from 2022 to 2028. Growing Prevalence of Respiratory Diseases Fuels North America Ventilators Market Respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, acute lower respiratory tract infections, tuberculosis, and lung cancer are among the most common causes of severe illness and death across North America. Urbanization, rise in pollution, unhealthy lifestyle habits, and high tobacco smoking prevalence are a few of the major factors leading to the surge in the number of respiratory and cardiovascular disease cases. ๐Ÿ“š ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/BMIRE00028250 Such disease can cause acute respiratory failure, and its treatment requires mechanical ventilation. As per the Office of Disease Prevention and Health Promotio...
Read more